GXC:ARCA-SPDR S&P China (USD)

ETF | China Region | NYSE Arca

Last Closing

USD 68.45

Change

0.00 (0.00)%

Market Cap

USD 0.83B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks investment results that, before fees and expenses, correspond generally to the total return performance of the S&P China BMI Index. The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index or in American Depositary Receipts ("ADRs") or Global Depositary Receipts ("GDRs") based on securities comprising the index. The index is a market capitalization weighted index designed to define and measure the investable universe of publicly traded companies domiciled in China available to foreign investors. The fund is non-diversified.

Inception Date: 19/03/2007

Primary Benchmark: S&P China BMI NR USD

Primary Index: MSCI ACWI Ex USA NR USD

Gross Expense Ratio: 0.59%

Management Expense Ratio: 0.59 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-29 )

Largest Industry Peers for China Region

Symbol Name Mer Price(Change) Market Cap
KWEB KraneShares CSI China Internet.. 0.75 %

+0.08 (+0.30%)

USD 5.42B
EWT iShares MSCI Taiwan ETF 0.59 %

-0.14 (-0.26%)

USD 5.31B
FXI iShares China Large-Cap ETF 0.74 %

+0.09 (+0.35%)

USD 4.53B
ASHR Xtrackers Harvest CSI 300 Chin.. 0.65 %

+0.11 (+0.47%)

USD 1.89B
CQQQ Invesco China Technology ETF 0.70 %

N/A

USD 0.65B
EWH iShares MSCI Hong Kong ETF 0.48 %

-0.02 (-0.13%)

USD 0.49B
FLTW Franklin FTSE Taiwan ETF 0.19 %

-0.07 (-0.14%)

USD 0.24B
CHIQ Global X MSCI China Consumer D.. 0.65 %

+0.10 (+0.60%)

USD 0.22B
KBA KraneShares Bosera MSCI China .. 0.60 %

+0.10 (+0.45%)

USD 0.18B
FLCH Franklin FTSE China ETF 0.19 %

+0.09 (+0.57%)

USD 0.11B

ETFs Containing GXC

MCRO 0.00 % 0.76 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (China Region) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.48% 68% D+ 43% F
Dividend Return 0.92% 57% F 28% F
Total Return 1.40% 68% D+ 38% F
Trailing 12 Months  
Capital Gain -7.21% 63% D 21% F
Dividend Return 3.14% 80% B- 46% F
Total Return -4.08% 68% D+ 21% F
Trailing 5 Years  
Capital Gain -29.82% 47% F 20% F
Dividend Return 8.27% 56% F 30% F
Total Return -21.56% 53% F 18% F
Average Annual (5 Year Horizon)  
Capital Gain -4.55% 37% F 19% F
Dividend Return -2.91% 37% F 15% F
Total Return 1.64% 63% D 39% F
Risk Return Profile  
Volatility (Standard Deviation) 25.42% 68% D+ 41% F
Risk Adjusted Return -11.45% 32% F 23% F
Market Capitalization 0.83B 68% D+ 45% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.